Weekly
Chinese provinces are rolling out BCI industrial documents, with Beijing and Zhejiang already covering them through medical insurance. Yet the targets are inconsistent. Among 12 documents, only Shanghai pins 2030 indicators to specific indications, such as restoring vision for blind patients and tactile sense for paralyzed patients. Most provinces only promise product counts and industrial scale, leaving varied acceptance criteria.
08-25China's first multicenter closed-loop BCI trial for refractory depression starts in Shanghai and Beijing, covering two routes with randomized sham control. It could offer a new option for drug-resistant patients. Watch enrollment and control design.
08-25LibriBrain100 is the largest intra-subject MEG dataset of its kind, lifting the noninvasive speech decoding benchmark from hours to 80 hours. It comes with open-source tools and a competition. Worth downloading for standardized evaluation.
08-28It turns ethical issues into process variables, showing how decoding uncertainty can become care misjudgment.
08-260.45 ms added latency buys practical post-quantum security for distributed BCI without hurting real-time.
08-25A registered rehabilitation trial with clear design, useful as a benchmark for similar projects.
08-25First sponsor-led trial of a wireless implantable BCI; safety data will shape invasive confidence.
